Geographic Differences in the Growth of Open Access Publishing

Geographic Differences in the Growth of Open Access Publishing

  • ISMPP 2020 London
  • Jan 2020
Approaches to the Collection of Utility Values for Rare Diseases

Approaches to the Collection of Utility Values for Rare Diseases

  • ISPOR Copenhagen 2019
  • Nov 2019
Impact of Generics and Biosimilars on Branded Drug Listing Decisions in Singapore

Impact of Generics and Biosimilars on Branded Drug Listing Decisions in Singapore

  • ISPOR 2019 Copenhagen
  • Nov 2019
Development, Validation and Concordance of Clinical Code Sets Used in Real-World Database Studies

Development, Validation and Concordance of Clinical Code Sets Used in Real-World Database Studies

  • ISPOR 2019 Copenhagen
  • Nov 2019
To What Extent Does Seeking Clinical Expert Opinion for Model Inputs Reduce the Cost of Uncertainty? A Conceptual Approach Using Expected Value of Perfect Parameter Information (EVPPI)

To What Extent Does Seeking Clinical Expert Opinion for Model Inputs Reduce the Cost of Uncertainty? A Conceptual Approach Using Expected Value of Perfect Parameter Information (EVPPI)

  • ISPOR 2019 Copenhagen
  • Nov 2019
Trust the Experts? Acceptance of Expert Elicitation in the National Institute for Health and Care Excellence (NICE) Single Technology Appraisal (STA) Process

Trust the Experts? Acceptance of Expert Elicitation in the National Institute for Health and Care Excellence (NICE) Single Technology Appraisal (STA) Process

  • ISPOR 2019 Copenhagen
  • Nov 2019
Parallel Scientific Advice from NICE and CADTH: Would One Submission Fit All?

Parallel Scientific Advice from NICE and CADTH: Would One Submission Fit All?

  • ISPOR 2019 Copenhagen
  • Nov 2019
Accurate Predictions of Life Year Gains for Immuno-Oncology Therapies in the Long Term? An Analysis Based on Published Checkmate 057 Nivolumab Data

Accurate Predictions of Life Year Gains for Immuno-Oncology Therapies in the Long Term? An Analysis Based on Published Checkmate 057 Nivolumab Data

  • ISPOR 2019 Copenhagen
  • Nov 2019
Real-World Evidence in Gene Therapies: Recommendations Versus Reality

Real-World Evidence in Gene Therapies: Recommendations Versus Reality

  • ISPOR 2019 Copenhagen
  • Nov 2019
Influencing ICER: A Review of Manufacturer Involvement in ICER Assessments

Influencing ICER: A Review of Manufacturer Involvement in ICER Assessments

  • ISPOR 2019 New Orleans
  • Jun 2019
Real-World Evidence on the Rise: Evaluating the Use of Real-World Evidence in ICER Assessments of Comparative Clinical Effectiveness

Real-World Evidence on the Rise: Evaluating the Use of Real-World Evidence in ICER Assessments of Comparative Clinical Effectiveness

  • ISPOR 2019 New Orleans
  • May 2019
Patient, Payer and Manufacturer Perspectives on Four Cost-Control Mechanisms for Pharmaceuticals

Patient, Payer and Manufacturer Perspectives on Four Cost-Control Mechanisms for Pharmaceuticals

  • ISPOR 2019 New Orleans
  • May 2019
Loading